(Français) Migration cellulaire ou “l’art de se choisir un bon leader”
24.02.2014 - Press release
(Français) Des cellules qui progressent tout en gardant des interactions fortes entre elles désignent parmi elle un leader : cette cellule entraîne toutes les autres comme un seul homme. Telle est la découverte d’un travail collaboratif entre physiciens et biologistes de l'Inserm ...
Enhancement of chemotherapy by prevention of tumour cell repair
20.02.2014 - Press release
A team of researchers directed by Frédéric Coin, Inserm Research Director at the Institute of Genetics and Molecular and Cellular Biology (IGBMC) in Strasbourg (a Joint Inserm/CNRS/University of Strasbourg Research Unit), has discovered a new drug that inhibits repair: spironolactone, which seems ...
Leukemia: mode of action of a targeted treatment clarified
13.01.2014 - Press release
The mechanism of senescence - or premature cell ageing - can have an anticancer effect. This new work, conducted by Hugues de Thé and his team (Paris Diderot University/ Inserm/ CNRS/ AP-HP), was published in Nature Medicine on 12 January 2014. ...
Mechanics and genetics: an indispensable cocktail for embryonic development
27.11.2013 - Press release
In the fruit fly Drosophila and zebrafish, mechanical strain may activate the genetic cascade that initiates the formation of the future organs during embryogenesis. A discovery made by Emmanuel Farge (Inserm Research Director at Institut Curie) and his staff might explain the ...
Chemotherapy: when our intestinal bacteria provide reinforcement
22.11.2013 - Press release
Research jointly conducted by investigators at Institut Gustave Roussy, Inserm, Institut Pasteur and INRA (French National Agronomic Research Institute) has led to a rather surprising discovery on the manner in which cancer chemotherapy treatments act more effectively with the help of the ...
Cancer treatment: a step towards personalized chronotherapy
18.11.2013 - Press release
An international study conducted on mice and coordinated by researchers from Inserm, CNRS and Université Paris-Sud has paved the way towards personalized chronotherapy treatments. In an article published in the journal Cancer Research, the team has shown that the timing of optimal ...